Tags:
I think we will all have specific things that we remember specifically; for me it is byglican will be in trial around the 2010-2011 timeframe with Summet's Utrophin within 18 mths. There is also Debio-025 from Cincinatti in conjunction with a Swiss lab that will be in the 2010 time frame as well. it was agreed by all that the answer is closer, but it will still be a cocktail...albeit a good one!Any news about clinical trials other than what we already know: Prosensa's proof of principle completed, systemic delivery started May '08; MDEX proof of principle started Dec '07; Summit's utrophin upregulation scheduled to start '09.
What about MDEX/AVI systemic delivery for exon 51 (any news about their proof of principle?), Byglican, Losartan etc.???
Ofelia Marin said:I think we will all have specific things that we remember specifically; for me it is byglican will be in trial around the 2010-2011 timeframe with Summet's Utrophin within 18 mths. There is also Debio-025 from Cincinatti in conjunction with a Swiss lab that will be in the 2010 time frame as well. it was agreed by all that the answer is closer, but it will still be a cocktail...albeit a good one!Any news about clinical trials other than what we already know: Prosensa's proof of principle completed, systemic delivery started May '08; MDEX proof of principle started Dec '07; Summit's utrophin upregulation scheduled to start '09.
What about MDEX/AVI systemic delivery for exon 51 (any news about their proof of principle?), Byglican, Losartan etc.???
the good thing about utrophin upregulation, since we already have this in our system, is that the initial trial in humans can be done with healthy subjects.
Hey everyone-
We hope to have slides up in the coming weeks, I will also be working on gettting podcasts of some of the sessions as well.
I'll be in touch!
Ryan
© 2022 Created by PPMD.
Powered by
Badges | Report an Issue | Privacy Policy | Terms of Service